MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1365-2036.1989.tb00253.x

Медицинская библиотека · Alimentary pharmacology & therapeutics · 1989

Mesalazine in childhood inflammatory bowel disease.

Barden L, Lipson A, Pert P, Walker-Smith J A

Сравнительное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

A study was undertaken in paediatric patients suffering from ulcerative, Crohn's or indeterminate colitis. This aimed to compare the occurrence and tolerance of side-effects arising during treatment with position-release mesalazine (Asacol) with those occurring during previous treatment with sulphasalazine (Salazopyrin). The drugs were used to maintain remission from colitis. The occurrence of adverse reactions was also monitored. Sixty-seven children were assessed for a period of 6 months; 45 of these children received mesalazine after previous treatment with sulphasalazine. The results show that the majority of patients were maintained in remission with either drug, but they reported a preference for position-release mesalazine with respect to ease and frequency of administration when compared to sulphasalazine. No serious adverse reactions arose during mesalazine treatment, compared with three such events during previous sulphasalazine treatment.

Для цитирования: Barden L, Lipson A, Pert P, Walker-Smith J A. Mesalazine in childhood inflammatory bowel disease.. Alimentary pharmacology & therapeutics. 1989. DOI: 10.1111/j.1365-2036.1989.tb00253.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.